DYNAVAX TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-05-28: Reporting owner CANO FRANCIS; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-05-28: Reporting owner ORONSKY ARNOLD L; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-05-28: Reporting owner CARSON DENNIS; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-05-28: Reporting owner DINA DINO; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-05-28 | CANO FRANCIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | ORONSKY ARNOLD L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | CARSON DENNIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | DINA DINO Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | GILBERT DENISE Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | KISNER DANIEL L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | Phillips Peggy V Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | Plotkin Stanley A Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-05-28 | RICCIARDI NATALE S Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $1.44 exercise price | 2014-05-29 | |
| 2014-02-05 | Johnson David Louis Officer (Vice President & CAO) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.69 exercise price | 2014-02-06 | |
| 2014-02-04 | OSTRACH MICHAEL S Officer (VP, CBO, and General Counsel) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +270,000 270,000 owned after | $1.71 exercise price | 2014-02-06 | |
| 2014-02-04 | Janssen Robert Officer (Chief Medical Officer and VP) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +180,000 180,000 owned after | $1.71 exercise price | 2014-02-06 | |
| 2014-02-04 | Novack David F Officer (Senior Vice President) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +220,000 220,000 owned after | $1.71 exercise price | 2014-02-06 | |
| 2014-02-04 | Gray Eddie Director, Officer (CEO and Director) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,500,000 1,500,000 owned after | $1.71 exercise price | 2014-02-06 | |
| 2014-01-31 | Gray Eddie Director, Officer (CEO and Director) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +750,000 750,000 owned after | $1.74 exercise price | 2014-02-04 |